Literature DB >> 32402920

A modified T categorization for part-solid lesions in Chinese patients with clinical stage I Non-small cell lung cancer.

Jiajun Deng1, Mengmeng Zhao1, Tingting Wang2, Yunlang She1, Junqi Wu1, Haoran E1, Jiani Gao1, Xiwen Sun2, Gening Jiang1, Yuming Zhu1, Dong Xie3, Chang Chen4.   

Abstract

OBJECTIVES: We evaluated the prognostic impact of the presence of ground glass opacity (GGO) component and compared a modified clinical T categorization (cTm) with the current 8th classification (cT8) for survival prediction in Chinese patients with clinical stage I non-small cell lung cancer (NSCLC).
METHODS: According to cTm and cT8 classifications, we retrospectively evaluated 1461 patients with part-solid or pure-solid lesions. The recurrence-free survival (RFS) and overall survival (OS) were analyzed by Kaplan-Meier method and Cox proportional hazard model. The concordance index (C- index), reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA) were performed to estimate reclassification net benefits of cTm for survival prediction.
RESULTS: The cT8 classification clearly stratifies the survival outcomes in solid tumors but not in part-solid tumors. The presence of GGO components was an independent prognostic factor for both RFS and OS (p < 0.001), indicating a better outcome in each clinical T stage. The C-index was significantly improved from 0.650 to 0.730 for RFS (p < 0.001) and 0.647 to 0.730 for OS (p < 0.001) after reclassifying by cTm categorization. The DCA, NRI (RFS: 0.342, OS: 0.302), and IDI (RFS: 0.070, OS: 0.054) demonstrated that the cTm classification provided more net benefit in the survival prediction compared with the current cT8 classification.
CONCLUSIONS: The current cT8 classification may not be appropriate for part-solid lesions because the presence of GGO components is associated with excellent prognosis despite clinical stage. Also, the cTm classification for part-solid lesions showed an improvement in survival prediction.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ground glass opacity; Non–small cell lung cancer; Survival

Mesh:

Year:  2020        PMID: 32402920     DOI: 10.1016/j.lungcan.2020.04.028

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  2 in total

1.  Prognostic Stratification According to Size and Dominance of Radiologic Solid Component in Clinical Stage IA Lung Adenocarcinoma.

Authors:  Masayuki Nakao; Katsunori Oikado; Yoshinao Sato; Kohei Hashimoto; Junji Ichinose; Yosuke Matsuura; Sakae Okumura; Hironori Ninomiya; Mingyon Mun
Journal:  JTO Clin Res Rep       Date:  2022-01-21

2.  A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I-IIIA non-small cell lung cancer after resection.

Authors:  Lili Xu; Yingbin Luo; Jianchun Wu; Yan Li; Jianhui Tian; Zhihong Fang; Weikang Zhu; Bo Zhang
Journal:  Ann Transl Med       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.